scholarly journals Activation of rat liver branched-chain 2-oxo acid dehydrogenase in vivo by glucagon and adrenaline

1985 ◽  
Vol 232 (2) ◽  
pp. 593-597 ◽  
Author(s):  
K P Block ◽  
B W Heywood ◽  
M G Buse ◽  
A E Harper
Keyword(s):  
Cyclic Amp ◽  
Fold Increase ◽  
Amino Acid Uptake ◽  
Acid Uptake ◽  
Acid Dehydrogenase ◽  
Low Protein ◽  
Branched Chain ◽  
Protein Diets ◽  
In Vivo Administration

The activity of liver branched-chain 2-oxo acid dehydrogenase complex was measured in rats fed on low-protein diets and given adrenaline, glucagon, insulin or dibutyryl cyclic AMP in vivo. Administration of glucagon or adrenaline (200 micrograms/100 g body wt.) resulted in a 4-fold increase in the percentage of active complex. As with glucagon and adrenaline, treatment of rats with cyclic AMP (5 mg/100 g body wt.) resulted in marked activation of branched-chain 2-oxo acid dehydrogenase. Insulin administration (1 unit/100 g body wt.) also resulted in activation of enzyme; however, these effects were less than those observed with glucagon and adrenaline. In contrast with the results obtained with low-protein-fed rats, administration of adrenaline (200 micrograms/100 g body wt.) to rats fed with an adequate amount of protein resulted in only a modest (14%) increase in the activity of the complex. The extent to which these hormones activate branched-chain 2-oxo acid dehydrogenase appears to be correlated with their ability to stimulate amino acid uptake into liver.

scholarly journals Effects of clofibric acid on the activity and activity state of the hepatic branched-chain 2-oxo acid dehydrogenase complex

1992 ◽  
Vol 285 (1) ◽  
pp. 167-172 ◽  
Author(s):  
Y Zhao ◽  
J Jaskiewicz ◽  
R A Harris
Keyword(s):  
Active Form ◽  
Clofibric Acid ◽  
Chow Diet ◽  
Acid Dehydrogenase ◽  
Low Protein ◽  
Activity State ◽  
Branched Chain ◽  
Acid Dehydrogenase Complex ◽  
Dehydrogenase Complex

Feeding clofibric acid to rats caused little or no change in total activity of the liver branched-chain 2-oxo acid dehydrogenase complex (BCODC). No change in mass of liver BCODC was detected by immunoblot analysis in response to dietary clofibric acid. No changes in abundance of mRNAs for the BCODC E1 alpha, E1 beta and E2 subunits were detected by Northern-blot analysis. Likewise, dietary clofibric acid had no effect on the activity state of liver BCODC (percentage of enzyme in the dephosphorylated, active, form) of rats fed on a chow diet. However, dietary clofibric acid greatly increased the activity state of liver BCODC of rats fed on a diet deficient in protein. No stable change in liver BCODC kinase activity was found in response to clofibric acid in either chow-fed or low-protein-fed rats. Clofibric acid had a biphasic effect on flux through BCODC in hepatocytes prepared from low-protein-fed rats. Stimulation of BCODC flux at low concentrations was due to clofibric acid inhibition of BCODC kinase, which in turn allowed activation of BCODC by BCODC phosphatase. Inhibition of BCODC flux at high concentrations was due to direct inhibition of BCODC by clofibric acid. The results suggest that the effects of clofibric acid in vivo on branched-chain amino acid metabolism can be explained by the inhibitory effects of this drug on BCODC kinase.

scholarly journals Studies on Aromatic Amino Acid Uptake by Rat Brain in Vivo

1962 ◽  
Vol 237 (3) ◽  
pp. 803-806
Author(s):  
Gordon Guroff ◽  
Sidney Udenfriend
Keyword(s):  
Amino Acid ◽  
Rat Brain ◽  
Aromatic Amino Acid ◽  
Amino Acid Uptake ◽  
Acid Uptake

Somatostatin inhibits insulin-stimulated amino acid uptake into cultured rat myoblasts

1987 ◽  
Vol 114 (4) ◽  
pp. 470-474 ◽  
Author(s):  
G. S. G. Spencer ◽  
D. J. Hill ◽  
G. J. Garssen ◽  
J. P. G. Williams
Keyword(s):  
Amino Acid ◽  
Nutrient Uptake ◽  
Monolayer Culture ◽  
Amino Acid Uptake ◽  
Inhibitory Effect ◽  
Isobutyric Acid ◽  
Acid Uptake ◽  
Newborn Rat ◽  
Amino Isobutyric Acid

Abstract. The effects of somatostatin on the acute metabolic actions of insulin on newborn rat myoblasts in culture has been examined during monolayer culture. Somatostatin significantly inhibited the insulin-stimulated uptake of [3H]leucine and [3H]amino-isobutyric acid into myoblasts but had no effect on basal (unstimulated) uptake of these two substances. The lowest concentration of somatostatin to have a significant effect was 10 μg/l, and this was apparent in all the experiments undertaken. The inhibitory effect of somatostatin was seen at all effective concentrations of insulin used (0.3–1 U/l). These findings lend support to the concept of an endocrine role for somatostatin in vivo and suggest that a peripheral antagonism may exist between circulating insulin and somatostatin on anabolic processes such as nutrient uptake into cells.

Removal of infused amino acids by splanchnic and leg tissues in humans

1986 ◽  
Vol 250 (4) ◽  
pp. E407-E413 ◽  
Author(s):  
R. A. Gelfand ◽  
M. G. Glickman ◽  
R. Jacob ◽  
R. S. Sherwin ◽  
R. A. DeFronzo
Keyword(s):  
Skeletal Muscle ◽  
Amino Acids ◽  
Amino Acid ◽  
Amino Acid Uptake ◽  
Branched Chain Amino Acids ◽  
Acid Uptake ◽  
Acid Infusion ◽  
Amino Acid Infusion ◽  
Significant Uptake ◽  
Branched Chain

To compare the contributions of splanchnic and skeletal muscle tissues to the disposal of intravenously administered amino acids, regional amino acid exchange was measured across the splanchnic bed and leg in 11 normal volunteers. Postabsorptively, net release of amino acids by leg (largely alanine and glutamine) was complemented by the net splanchnic uptake of amino acids. Amino acid infusion via peripheral vein (0.2 g X kg-1 X h-1) caused a doubling of plasma insulin and glucagon levels and a threefold rise in blood amino acid concentrations. Both splanchnic and leg tissues showed significant uptake of infused amino acids. Splanchnic tissues accounted for approximately 70% of the total body amino acid nitrogen disposal; splanchnic uptake was greatest for the glucogenic amino acids but also included significant quantities of branched-chain amino acids. In contrast, leg amino acid uptake was dominated by the branched-chain amino acids. Based on the measured leg balance, body skeletal muscle was estimated to remove approximately 25-30% of the total infused amino acid load and approximately 65-70% of the infused branched-chain amino acids. Amino acid infusion significantly stimulated both the leg efflux and the splanchnic uptake of glutamine (not contained in the infusate). We conclude that when amino acids are infused peripherally in normal humans, splanchnic viscera (liver and gut) are the major sites of amino acid disposal.

Insulin stimulates branched chain amino acid uptake and diminishes nitrogen flux from skeletal muscle of injured patients

1986 ◽  
Vol 40 (4) ◽  
pp. 395-405 ◽  
Author(s):  
David C. Brooks ◽  
Palmer Q. Bessey ◽  
Preston R. Black ◽  
Thomas T. Aoki ◽  
Douglas W. Wilmore
Keyword(s):  
Skeletal Muscle ◽  
Amino Acid ◽  
Amino Acid Uptake ◽  
Acid Uptake ◽  
Nitrogen Flux ◽  
Branched Chain Amino Acid ◽  
Branched Chain ◽  
Injured Patients

Hepatic Amino Acid Uptake Is Decreased in Lactating Rats. In Vivo and In Vitro Studies

1994 ◽  
Vol 124 (11) ◽  
pp. 2163-2171 ◽  
Author(s):  
José García de la Asunción ◽  
Amparo Devesa ◽  
Juan R. Viña ◽  
Teresa Barber
Keyword(s):  
Amino Acid ◽  
Amino Acid Uptake ◽  
In Vitro Studies ◽  
Acid Uptake

scholarly journals Alteration in gene expression of branched-chain keto acid dehydrogenase kinase but not in gene expression of its substrate in the liver of clofibrate-treated rats

1996 ◽  
Vol 317 (2) ◽  
pp. 411-417 ◽  
Author(s):  
Harbhajan S. PAUL ◽  
Wei-Qun LIU ◽  
Siamak A. ADIBI
Keyword(s):  
Gene Expression ◽  
Rat Liver ◽  
Fold Increase ◽  
Branched Chain Amino Acids ◽  
The Other ◽  
Mrna Levels ◽  
Keto Acid ◽  
Protein Mass ◽  
Acid Dehydrogenase ◽  
Branched Chain

We previously showed that the oxidation of branched-chain amino acids is increased in rats treated with clofibrate [Paul and Adibi (1980) J. Clin. Invest. 65, 1285–1293]. Two subsequent studies have reported contradictory results regarding the effect of clofibrate treatment on gene expression of branched-chain keto acid dehydrogenase (BCKDH) in rat liver. Furthermore, there has been no previous study of the effect of clofibrate treatment on gene expression of BCKDH kinase, which regulates the activity of BCKDH by phosphorylation. The purpose of the present study was to investigate the above issues. Clofibrate treatment for 2 weeks resulted in (a) a 3-fold increase in the flux through BCKDH in mitochondria isolated from rat liver, and (b) a modest but significant increase in the activity of BCKDH. However, clofibrate treatment had no significant effect on the mass of E1α, E1β, and E2 subunits of BCKDH or the abundance of mRNAs encoding these subunits. On the other hand, clofibrate treatment significantly reduced the activity, the protein mass and the mRNA levels of BCKDH kinase in the liver. In contrast to the results obtained in liver, clofibrate treatment had no significant effect on any of these parameters of BCKDH kinase in the skeletal muscle. In conclusion, our results show that clofibrate treatment increases the activity of BCKDH in the liver and the mechanism of this effect is the inhibition of gene expression of the BCKDH kinase.

scholarly journals Chemically modified antigen preferentially elicits induction of Th1-like cytokine synthesis patterns in vivo.

1993 ◽  
Vol 178 (1) ◽  
pp. 349-353 ◽  
Author(s):  
X Yang ◽  
R S Gieni ◽  
T R Mosmann ◽  
K T HayGlass
Keyword(s):  
Vaccine Development ◽  
Ex Vivo ◽  
Fold Increase ◽  
T Cell Subsets ◽  
Cytokine Gene Expression ◽  
Protein Antigens ◽  
Ifn Gamma ◽  
Cytokine Synthesis ◽  
In Vivo Administration

Differential activation of CD4+ T cell subsets in vivo leads to the development of qualitatively different effector responses. We identify an approach that allows selective activation of strongly Th1-dominated immune responses to protein antigens. Whereas in vivo administration of ovalbumin (OVA) induces cytokine synthesis that is neither Th1 nor Th2 dominated, administration of glutaraldehyde polymerized, high relative molecular weight OVA (OA-POL) leads to 20-fold increase in the ratio of interferon gamma (IFN-gamma)/IL-4 and IFN-gamma/IL-10 synthesis observed after short-term, antigen-mediated restimulation directly ex vivo. In contrast, concurrent in vivo administration of anti-IFN-gamma mAb and OVA or OA-POL results in marked increases in IL-4 and IL-10, and decreased IFN-gamma production, reflecting a polarization of the response towards a Th2-like pattern of cytokine synthesis. These observations may be useful in clinical settings including hypersensitivity, autoimmune diseases, and vaccine development where the ability to actively select specific patterns of cytokine gene expression would be advantageous.

Lack of effects of hypothermia on cerebral amino acid uptake in vivo

1977 ◽  
Vol 125 (1) ◽  
pp. 187-191 ◽  
Author(s):  
Emirbek Z. Emirbekov ◽  
Henry Sershen ◽  
Abel Lajtha
Keyword(s):  
Amino Acid ◽  
Amino Acid Uptake ◽  
Acid Uptake

scholarly journals Stimulation by 6-N,2′-O-dibutyryladenosine 3′:5′-cyclic monophosphate and glucocorticoids of phosphoenolpyruvate carboxykinase in the isolated perfused rat liver (Short Communication)

1974 ◽  
Vol 142 (3) ◽  
pp. 691-693 ◽  
Author(s):  
Wieland B. Huttner ◽  
Wilhelm Krone ◽  
Hans J. Seitz ◽  
Wolfgang Tarnowski
Keyword(s):  
Cyclic Amp ◽  
Cyclic Nucleotide ◽  
Time Course ◽  
Phosphoenolpyruvate Carboxykinase ◽  
Direct Action ◽  
Isolated Perfused Rat Liver ◽  
Dibutyryl Cyclic Amp ◽  
Low Protein ◽  
Additive Increase

Dibutyryl cyclic AMP stimulated the activity of phosphoenolpyruvate carboxykinase in perfused livers of rats, fed on a low-protein diet, linearly over a 6h period. The enzyme activity was also significantly elevated by dexamethasone, the effect being considerably lower than that of the cyclic nucleotide. Since the time-course of phosphoenolpyruvate carboxykinase activity in response to dibutyryl cyclic AMP resembled that observed after dibutyryl cyclic AMP injection into intact animals, it is suggested that induction of the enzyme in vivo is due to a direct action of the cyclic nucleotide on the liver. Combined administration of dibutyryl cyclic AMP and glucocorticoids did not lead to an additive increase of liver phosphoenolpyruvate carboxykinase activity, either in vivo or in the perfused organ.

Sign in / Sign up

Export Citation Format

Share Document